Join
Live feed
·
INSIDERFilingvia Quantisnow
Vistagen Therapeutics Inc. logo

CHIEF EXECUTIVE OFFICER Singh Shawn was granted 4,854 shares, increasing direct ownership by 86% to 10,487 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VTGN· Vistagen Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTGN (Vistagen Therapeutics Inc.) and more on Quantisnow.